These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 16882717)
1. Unique players in the BMP pathway: small C-terminal domain phosphatases dephosphorylate Smad1 to attenuate BMP signaling. Knockaert M; Sapkota G; Alarcón C; Massagué J; Brivanlou AH Proc Natl Acad Sci U S A; 2006 Aug; 103(32):11940-5. PubMed ID: 16882717 [TBL] [Abstract][Full Text] [Related]
2. Dephosphorylation of the linker regions of Smad1 and Smad2/3 by small C-terminal domain phosphatases has distinct outcomes for bone morphogenetic protein and transforming growth factor-beta pathways. Sapkota G; Knockaert M; Alarcón C; Montalvo E; Brivanlou AH; Massagué J J Biol Chem; 2006 Dec; 281(52):40412-9. PubMed ID: 17085434 [TBL] [Abstract][Full Text] [Related]
3. C-terminal domain (CTD) small phosphatase-like 2 modulates the canonical bone morphogenetic protein (BMP) signaling and mesenchymal differentiation via Smad dephosphorylation. Zhao Y; Xiao M; Sun B; Zhang Z; Shen T; Duan X; Yu PB; Feng XH; Lin X J Biol Chem; 2014 Sep; 289(38):26441-26450. PubMed ID: 25100727 [TBL] [Abstract][Full Text] [Related]
4. Endofin acts as a Smad anchor for receptor activation in BMP signaling. Shi W; Chang C; Nie S; Xie S; Wan M; Cao X J Cell Sci; 2007 Apr; 120(Pt 7):1216-24. PubMed ID: 17356069 [TBL] [Abstract][Full Text] [Related]
5. Protein phosphatase magnesium-dependent 1A-mediated inhibition of BMP signaling is independent of Smad dephosphorylation. Kokabu S; Nojima J; Kanomata K; Ohte S; Yoda T; Fukuda T; Katagiri T J Bone Miner Res; 2010 Mar; 25(3):653-60. PubMed ID: 19594322 [TBL] [Abstract][Full Text] [Related]
6. PP2A regulates BMP signalling by interacting with BMP receptor complexes and by dephosphorylating both the C-terminus and the linker region of Smad1. Bengtsson L; Schwappacher R; Roth M; Boergermann JH; Hassel S; Knaus P J Cell Sci; 2009 Apr; 122(Pt 8):1248-57. PubMed ID: 19339557 [TBL] [Abstract][Full Text] [Related]
7. Protein serine/threonine phosphatase PPM1A dephosphorylates Smad1 in the bone morphogenetic protein signaling pathway. Duan X; Liang YY; Feng XH; Lin X J Biol Chem; 2006 Dec; 281(48):36526-32. PubMed ID: 16931515 [TBL] [Abstract][Full Text] [Related]
8. Phospho-Smad1 modulation by nedd4 E3 ligase in BMP/TGF-β signaling. Kim BG; Lee JH; Yasuda J; Ryoo HM; Cho JY J Bone Miner Res; 2011 Jul; 26(7):1411-24. PubMed ID: 21308777 [TBL] [Abstract][Full Text] [Related]
9. Specific control of BMP signaling and mesenchymal differentiation by cytoplasmic phosphatase PPM1H. Shen T; Sun C; Zhang Z; Xu N; Duan X; Feng XH; Lin X Cell Res; 2014 Jun; 24(6):727-41. PubMed ID: 24732009 [TBL] [Abstract][Full Text] [Related]
10. SANE, a novel LEM domain protein, regulates bone morphogenetic protein signaling through interaction with Smad1. Raju GP; Dimova N; Klein PS; Huang HC J Biol Chem; 2003 Jan; 278(1):428-37. PubMed ID: 12393873 [TBL] [Abstract][Full Text] [Related]
11. Identification of phosphatases for Smad in the BMP/DPP pathway. Chen HB; Shen J; Ip YT; Xu L Genes Dev; 2006 Mar; 20(6):648-53. PubMed ID: 16510868 [TBL] [Abstract][Full Text] [Related]
12. Suppression of BMP-Smad signaling axis-induced osteoblastic differentiation by small C-terminal domain phosphatase 1, a Smad phosphatase. Kokabu S; Ohte S; Sasanuma H; Shin M; Yoneyama K; Murata E; Kanomata K; Nojima J; Ono Y; Yoda T; Fukuda T; Katagiri T Mol Endocrinol; 2011 Mar; 25(3):474-81. PubMed ID: 21239611 [TBL] [Abstract][Full Text] [Related]
14. Visualizing Smad1/4 signaling response to bone morphogenetic protein-4 activation by FRET biosensors. Gromova KV; Friedrich M; Noskov A; Harms GS Biochim Biophys Acta; 2007 Dec; 1773(12):1759-73. PubMed ID: 18006160 [TBL] [Abstract][Full Text] [Related]
15. Mutations in bone morphogenetic protein type II receptor cause dysregulation of Id gene expression in pulmonary artery smooth muscle cells: implications for familial pulmonary arterial hypertension. Yang J; Davies RJ; Southwood M; Long L; Yang X; Sobolewski A; Upton PD; Trembath RC; Morrell NW Circ Res; 2008 May; 102(10):1212-21. PubMed ID: 18436795 [TBL] [Abstract][Full Text] [Related]
16. USP15 targets ALK3/BMPR1A for deubiquitylation to enhance bone morphogenetic protein signalling. Herhaus L; Al-Salihi MA; Dingwell KS; Cummins TD; Wasmus L; Vogt J; Ewan R; Bruce D; Macartney T; Weidlich S; Smith JC; Sapkota GP Open Biol; 2014 May; 4(5):140065. PubMed ID: 24850914 [TBL] [Abstract][Full Text] [Related]
17. Tbx2 mediates dorsal patterning and germ layer suppression through inhibition of BMP/GDF and Activin/Nodal signaling. Reich S; Kayastha P; Teegala S; Weinstein DC BMC Mol Cell Biol; 2020 May; 21(1):39. PubMed ID: 32466750 [TBL] [Abstract][Full Text] [Related]
18. Involvement of PRIP (Phospholipase C-Related But Catalytically Inactive Protein) in BMP-Induced Smad Signaling in Osteoblast Differentiation. Kotani M; Matsuda M; Murakami A; Takahashi I; Katagiri T; Hirata M J Cell Biochem; 2015 Dec; 116(12):2814-23. PubMed ID: 25981537 [TBL] [Abstract][Full Text] [Related]
20. The unique activity of bone morphogenetic proteins in bone: a critical role of the Smad signaling pathway. Katagiri T; Tsukamoto S Biol Chem; 2013 Jun; 394(6):703-14. PubMed ID: 23324379 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]